Growth Factors Beyond Teduglutide

  • Describe the principles of growth factor therapy in intestinal adaptation using teduglutide as the prototype growth factor
  • Summarize results of recent Phase 2 trials with long-acting growth factors in intestinal failure
  • Explain the future landscape for growth factor therapy in intestinal failure
Tuesday, February 4, 2020 - 1:00pm to 2:00pm
Palle Jeppesen, MD, Rigshospitalet, Copenhagen, Denmark
Age Cohort: